Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SENORES Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and improving operating margin
Strong revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low and declining Debt to Equity
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Moderate ROE but declining trend
Company's earnings are of low quality
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
SENORES Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SENORES Bulk, Block & Insider Trades
SENORES Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Senores Pharmaceuticals Limited is an India-based pharmaceutical company. The Company manufactures products of international quality to cater to the increasing new age demands of the global healthcare industry. The Companys products include Amphetamine Sulfate Tablets USP, 5 mg and 10 mg; Hydroxychl... Read More
Key personnel
Mr. Sanjay Shaileshbhai MajmudarD
Non-Executive Non-Independent Chairman of the Board
Mr. Deval Rajnikant ShahD
Chief Financial Officer, Whole Time Director
Mr. Chetan Bipinchand ShahD
Chief Operating Officer, Whole Time Director
Vinay Mishra
Compliance Officer, Company Secretary
Mr. Deepak Jain
Vice President - Regulatory Affairs
Mr. Swapnil Jatinbhai ShahD
Managing Director, Executive Director
Mr. Malay Patel
Assistant Vice President - Research and Development
Mr. Parag Shah
Assistant Vice President - Finance
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently Asked Questions about SENORES
What is the current share price of Senores Pharmaceuticals Ltd.?
The current share price of Senores Pharmaceuticals Ltd. is ₹ 779.83 as of 24 Feb 2026.
What is the PE ratio of Senores Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Senores Pharmaceuticals Ltd. is 35.35 as of the latest financial data.
What is the ROE and ROCE of Senores Pharmaceuticals Ltd.?
Senores Pharmaceuticals Ltd. has a Return on Equity (ROE) of 11.82% and a Return on Capital Employed (ROCE) of 9.02% as per the latest financial reports.
What is the market cap of Senores Pharmaceuticals Ltd.?
The market capitalization of Senores Pharmaceuticals Ltd. stands at ₹ 3,591.43 Cr.
What is the dividend yield of Senores Pharmaceuticals Ltd.?
The dividend yield of Senores Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the RSI of Senores Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Senores Pharmaceuticals Ltd. is 41.72.
What is the FII and DII holding in Senores Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 3.35% and Domestic Institutional Investors (DII) hold 7.55% of Senores Pharmaceuticals Ltd. shares.
What sector does Senores Pharmaceuticals Ltd. belong to?
Senores Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Senores Pharmaceuticals Ltd. stock?
The beta of Senores Pharmaceuticals Ltd. stock is 1.03, indicating its volatility relative to the broader market.
